30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

4Q13/2013 Revenue: Medicrea

4Q13 revenue: €5.8MM (~US $7.9MM), +18% (U.S. $4.5MM)

  • Resubmitted to FDA the approval file for K-JAWS cervical compression staple

 

2013 revenue: €22.9MM (~$31.2MM), +11% (U.S. +25%)

  • For 2014, company plans to open at least 1 new subsidiary in Germany and arrange distribution agreements in Asia, eastern Europe, Middle East